Page last updated: 2024-10-27

fluorouracil and Dyskeratosis Congenita

fluorouracil has been researched along with Dyskeratosis Congenita in 1 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Dyskeratosis Congenita: A predominantly X-linked recessive syndrome characterized by a triad of reticular skin pigmentation, nail dystrophy and leukoplakia of mucous membranes. Oral and dental abnormalities may also be present. Complications are a predisposition to malignancy and bone marrow involvement with pancytopenia. (from Int J Paediatr Dent 2000 Dec;10(4):328-34) The X-linked form is also known as Zinsser-Cole-Engman syndrome and involves the gene which encodes a highly conserved protein called dyskerin.

Research Excerpts

ExcerptRelevanceReference
" To examine the dosage effect of telomerase, we generated a line of mTR+/- mice on the CAST/EiJ background, which has short telomeres."1.33Short telomeres, even in the presence of telomerase, limit tissue renewal capacity. ( Armanios, M; Feldser, DM; Greider, CW; Hao, LY; Huso, D; Karim, B; Strong, MA, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hao, LY1
Armanios, M1
Strong, MA1
Karim, B1
Feldser, DM1
Huso, D1
Greider, CW1

Other Studies

1 other study available for fluorouracil and Dyskeratosis Congenita

ArticleYear
Short telomeres, even in the presence of telomerase, limit tissue renewal capacity.
    Cell, 2005, Dec-16, Volume: 123, Issue:6

    Topics: Animals; Anticipation, Genetic; Blood Cell Count; Bone Marrow Transplantation; Crosses, Genetic; Dys

2005